In a post-New Year’s Eve broadcast, Dr. Daniel Griffin and Vincent Racaniello of "This Week in Virology" (TWiV) have delivered…
Read More
TWiV 1285: Encapsidating Viruses 2025
The podcast "This Week in Virology" (TWiV) recently released its 1285th episode, offering a comprehensive review of compelling virology themes…
Read More
TWiV 1286: Clinical Update with Dr. Daniel Griffin Explores Alarming Shifts in Childhood Immunization and Enduring Public Health Challenges
In a recent clinical update on the "This Week in Virology" (TWiV) podcast, Dr. Daniel Griffin and host Vincent Racaniello…
Read More
TWiV 1287: Ancient herpesviruses and modern dementia
Virologists Uncover Deep History of Human Herpesviruses and Explore Shingles Vaccine’s Impact on Dementia In a wide-ranging discussion broadcast on…
Read More
TWiV 1288: Clinical update with Dr. Daniel Griffin
In a recent episode of the highly regarded scientific podcast "This Week in Virology" (TWiV), host Vincent Racaniello and clinical…
Read More
TWiV 1289: Building a Better Hepatitis B Trap
This Week in Virology (TWiV) episode 1289 delves into two significant breakthroughs in virology: the intricate mechanisms by which the…
Read More
TWiV 1290: Clinical Update with Dr. Daniel Griffin Explores Diverse Medical Topics from Screwworm to Scientific Advocacy
In a comprehensive clinical update featured on "This Week in Virology" (TWiV) episode 1290, Dr. Daniel Griffin, alongside host Vincent…
Read More
Biogen Acquires Apellis Pharmaceuticals for $5.6 Billion to Bolster Immunology and Rare Disease Portfolio
Biogen, a global biotechnology company renowned for its pioneering work in neuroscience, has announced a significant strategic acquisition of Apellis…
Read More
TWiV 1291: A Foot in the Door for Cytomegalovirus
This episode of "This Week in Virology" (TWiV) delves into two critical advancements in virology: the emergence of a neurovirulent…
Read More
TWiV 1292: Clinical update with Dr. Daniel Griffin
The United States’ withdrawal from the World Health Organization (WHO) and proposed changes to vaccine mandates have ignited significant debate…
Read MoreYOU MAY HAVE MISSED
